Company / Current Liabilities per Share
Arcadia Biosciences, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.51
FY2025
5-year range
$0.37 / $7.59
FY2021-FY2025
Trend
-24.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has declined for 3 consecutive years, from $7.59 in FY2022 to $1.51 in FY2025.
Based on SEC 10-K filings.
1.51 in FY2025 with a 5-year CAGR of +15.6%.
Improved from $5.83 to $1.51 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -41.6%
- 5-Year CAGR
- +15.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- Arcadia Biosciences, Inc.'s current liabilities per share has declined for 3 consecutive years.
- In FY2025, current liabilities per share decreased 24.3% year-over-year.
- Peak current liabilities per share was recorded in FY2022.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.51 | -24.3% |
| FY2024 | $1.99 | -65.8% |
| FY2023 | $5.83 | -23.2% |
| FY2022 | $7.59 | +1925.4% |
| FY2021 | $0.37 | -48.7% |
| FY2020 | $0.73 | -38.9% |
| FY2019 | $1.20 | -16.5% |
| FY2018 | $1.43 | -9.7% |
| FY2017 | $1.58 | +2137.7% |
| FY2016 | $0.07 | -95.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026